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The arterivirus porcine reproductive and respiratory syndrome virus (PRRSV) contains four
glycoproteins, GP2a, GP3, GP4 and GP5, the functions of which are still largely unresolved. In
this study, the significance of the N-glycosylation of the GP2a and GP5 proteins of PRRSV strain
LV was investigated. Both glycoproteins contain two predicted N-glycosylation sites that are
highly conserved between North American-type and European-type PRRSV. Using site-directed
mutagenesis, single and double mutant full-length PRRSV cDNA clones were generated.
After analysing the expression of the mutant proteins and the actual use of the four putative
glycosylation sites in the wild-type proteins, the production of mutant virus particles and their
infectivities were investigated. The results showed that the N-linked glycans normally present on
the GP2a protein are not essential for particle formation, as is the oligosaccharide attached to
N53 of the GP5 protein. In contrast, the oligosaccharide linked to N46 of the GP5 protein is
strongly required for virus particle production. The specific infectivities of the mutant viruses
were investigated by comparing their infectivity-per-particle ratios with that of wild-type virus.
The results showed that the lack of either one or both of the N-linked oligosaccharides on GP2a
or of the oligosaccharide attached to N53 of GP5 did not significantly affect the infectivities of
the viruses. In contrast, the two recombinant viruses lacking the oligosaccharide bound to
N46 exhibited a significantly reduced specific infectivity compared with the wild-type virus.
The implications of the differential requirements of the modifications of GP2a and GP5 for
PRRSV assembly and infectivity are discussed.
INTRODUCTION
Porcine reproductive and respiratory syndrome virus
(PRRSV) is a positive-strand RNA virus that has been
assigned to the family Arteriviridae. Other members of this
family are lactate dehydrogenase-elevating virus (LDV),
equine arteritis virus (EAV) and simian haemorrhagic fever
virus. The family Arteriviridae has been grouped within the
order Nidovirales together with the Coronaviridae and the
Roniviridae (Cavanagh, 1997; Cowley et al., 2000). PRRSV
strains have been grouped into North American- and
European-type strains on the basis of antigenic and genetic
differences between the isolates on the two continents
(reviewed by Meng, 2000).
PRRSV virions are spherical particles with a diameter
of 50–60 nm consisting of a putatively icosahedral core
surrounded by an envelope (Benfield et al., 1992). The
core contains the 15 kb genome packaged in a capsid
consisting of 14 kDa nucleocapsid protein (N) subunits.
In the envelope, up to six structural proteins have pres-
ently been identified, of which the most abundant are the
17 kDa non-glycosylated membrane protein (M) and the
25 kDa glycosylated GP5 protein, which occur as disulphide-
linked heterodimers (Mardassi et al., 1996; Meulenberg
et al., 1995). The topologies of the GP5 and M proteins have
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not yet been resolved, but, by analogy with LDV (Faaberg
& Plagemann, 1995), the M protein is predicted to be a
polytopic class III integral membrane protein with an
N-terminal ectodomain of only 16 amino acids, three
membrane-spanning domains and a C-terminal endo-
domain of about 78 amino acids (Meulenberg et al.,
1995). The GP5 protein is assumed to have a cleaved N-
terminal signal sequence of approximately 30 amino acids
followed by an ectodomain of approximately 35 amino
acids and a hydrophobic region of about 60 amino acids
that may span the membrane once or thrice. The 70 C-
terminal amino acids are thought to form an endodomain
(Meulenberg et al., 1995). The disulphide bond between
GP5 and M probably occurs between Cys
50 and Cys8 of the
respective proteins (Verheije, 2002).
The remaining envelope proteins are the GP2a, GP3 and
GP4 glycoproteins and the small, non-glycosylated E pro-
tein, each of which occurs only in minor quantities in the
viral envelope (Meulenberg & Petersen-den Besten, 1996;
van Nieuwstadt et al., 1996; Wu et al., 2001). The 29–30 kDa
GP2a and 31–35 kDa GP4 proteins are both putative class I
integral membrane proteins with a cleaved N-terminal
signal sequence and a C-terminal membrane anchor. The
45–50 kDa GP3 protein has an N-terminal hydrophobic
domain (Meulenberg et al., 1995). Conflicting data on the
presence of the GP3 protein in PRRSV particles have been
reported. For European-type strains, the GP3 protein was
found to be incorporated into virions (van Nieuwstadt et al.,
1996), whereas for North American strains the protein was
reported to be a soluble, secreted protein (Gonin et al., 1998;
Mardassi et al., 1998). This discrepancy might be real or
due to different analytical procedures. Recently, a study on
the minor glycoproteins of EAV showed these proteins to
occur in viral particles as covalently linked complexes, the
incorporation of which occurs in concert with that of the E
protein (Wieringa, 2003; Wieringa et al., 2003).
Based on the available data, the GP5 and M proteins of
PRRSV seem to play a role in virus assembly (Verheije,
2002). Such a function has been clearly demonstrated for
the GP5 and M proteins of EAV (Wieringa, 2003). More-
over, PRRSV GP5–M complexes were shown to interact
with heparin (Delputte et al., 2002), suggesting an additional
role in attachment of virus to alveolar macrophages. The
functions of the PRRSV minor envelope proteins, includ-
ing the E protein, are still unknown, but a recent study
showed that the homologous proteins of EAV are dis-
pensable for virus particle production. Since EAV particles
devoid of these proteins were non-infectious, the minor
envelope proteins are thought to be involved in EAV
tropism and entry (Wieringa, 2003). Correspondingly, the
minor envelope proteins of PRRSV might have a similar
role in PRRSV infection.
The importance of N-glycans for viral glycoprotein fold-
ing and functioning has become clear from many studies
(reviewed by Doms et al., 1993). For arteriviruses, a corre-
lation has been demonstrated between the number of
N-glycosylation sites on the ectodomain of the ORF5
product VP-3P of LDV and important biological properties
such as neuropathogenicity and susceptibility to immune
response (Chen et al., 2000), whereas mutation of the single
N-glycosylation site in the GP5 ectodomain of EAV
abolished virus particle production (Snijder et al., 2003).
For PRRSV, nothing is known about the significance of
any of its N-glycans in the viral life cycle. Of the four
glycoproteins, both the GP2a and GP5 protein have two
potential N-glycosylation sites, whereas computer analysis
indicates the presence of seven and four potential N-
glycosylation sites, respectively, in the GP3 and GP4 pro-
tein sequences (Meulenberg et al., 1995). Endoglycosidase
treatments suggested that all putative sites are occupied
by complex-type N-glycans (Meulenberg et al., 1995; van
Nieuwstadt et al., 1996).
In the present study, we investigated the role of N-
glycosylation of the GP2a and GP5 proteins in the PRRSV
life cycle. Comparative sequence analysis of the ORF2a
and ORF5 genes of European and North American PRRSV
isolates shows that the encoded proteins each share two
highly conserved putative glycosylation sites, suggesting
that they are functional and that the N-glycans are impor-
tant for folding or functioning of these glycoproteins. To
determine their significance for virus production and viral
infectivity, we generated recombinant viruses in which the
N-glycosylation sites were mutated. The mutant viruses
were then analysed for their capacity to produce infectious
viral particles.
METHODS
Cells and media. BHK-21 cells were grown in Glasgow minimal
essential medium (GMEM; Gibco-BRL) supplemented with 5 %
FBS, 10 % tryptose phosphate broth, 20 mM HEPES/NaOH (pH 7?4),
2 mM glutamine, 100 U penicillin ml21 and 100 U streptomycin ml21.
Porcine alveolar lung macrophages (PAMs) (Wensvoort et al., 1991)
were maintained in MCA-RPMI 1640 medium (Gibco-BRL) contain-
ing 5 % FBS, 500 U penicillin ml21 and 500 U streptomycin ml21.
Monoclonal antibodies and antisera. Monoclonal antibody
(mAb) P10/a46, directed against amino acids 29–35 of the GP5
protein of the PPV strain (Wissink et al., 2003), was generously
provided by Dr E. Weiland, Tu¨bingen, Germany. mAb 122.17 is
directed against the PRRSV N protein (van Nieuwstadt et al., 1996).
Polyclonal rabbit serum p690 was raised against a Lelystad virus
(LV)-specific peptide consisting of amino acids 64–78 of the GP2
protein (Meulenberg et al., 1995). LV was the first European isolate
described (Wensvoort et al., 1991).
Construction of mutant full-length cDNA clones. Mutations
affecting the N-linked glycosylation sites were introduced into
ORF2a and ORF5 in two different vectors, the pCIneo mammalian
expression vector (Promega) and pABV437, a PacI-mutant of the
genome-length cDNA clone of LV (Meulenberg et al., 1998). The
consensus sequences for N-linked glycosylation sites (N-X-S/T) in
the GP2a and GP5 proteins were altered by mutating the asparagine
(N) codon AAC/AAT into a glutamine (Q) codon CAG by perform-
ing a fusion PCR (Dekker et al., 2000). Glutamine was chosen
because of its similarity to asparagine. To generate the GP2a glycosy-
lation mutants, pABV437 (referred to below as wt-LV) was used as a
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template, whereas pABV911 (referred to below as wt-NS, neutralization-
sensitive) was used as a template to introduce an additional muta-
tion in the GP5 glycosylation mutants. The wt-NS virus is identical
to PRRSV LV except that it has a proline residue at position 24 of
the GP5 protein, which enables recognition of the mutant GP5 pro-
teins by neutralizing mAb P10/a46 (Wissink et al., 2003). Individual
parts were amplified with the forward or the reverse primer contain-
ing the desired mutation (for a detailed description of the primers,
see Table 1) and the two mutated PCR products were hybridized
together and amplified with two primers outside the mutated
region. The amplified fragments were then digested with the appro-
priate restriction enzymes (Table 1) and ligated into the similarly
digested pCIneo vector. Alternatively, the fragments were ligated
into the similarly digested plasmid pABV651, a cDNA clone contain-
ing the 39 end of the LV genome. From the resulting clones, the
AatII–HpaI fragment was excised and introduced into the unique
AatII/HpaI sites of pABV437. The following recombinant clones
were thus obtained: pABV832 (mutation N173Q in the GP2a pro-
tein, referred to as GP2a-N173Q), pABV833 (GP2a-N179Q),
pABV836 (GP5-N46Q) and pABV837 (GP5-N53Q) (see Fig. 1).
In order to generate constructs that contain two mutations, fusion
PCRs were performed on pABV832 and pABV836, yielding pABV847
(mutations N173Q and N179Q in the GP2a protein, referred to as
GP2a-double mutant) and pABV848 (GP5-double mutant). Cloning
procedures were as described above. All plasmids were verified by
restriction enzyme analysis and by sequencing of the entire PCR-
generated fragment.
In vitro RNA transcription and transfection of BHK-21 cells.
Full-length transcripts were generated in vitro from PvuI-linearized
cDNA clones. Fifty microlitre reaction mixtures consisting of 1?5 mg
plasmid DNA, 1 mM of each of the ribonucleotides ATP, CTP and
UTP and 0?5 mM GTP, 10 ml Transcription Optimized 56 buffer
(Promega), 1 mM capping analogue (m7G[59]ppp[59]G; New England
Biolabs), 3 ml RNasin (Promega), 1 mM DTT and 120 U T7 RNA
polymerase in water were incubated for 2 h at 37 uC. The yield and
quality of the RNAs were assessed by agarose gel electrophoresis,
after which the RNAs were transfected into BHK-21 cells by elec-
troporation as described by Liljestrom & Garoff (1993). Briefly,
subconfluent monolayers of 107 BHK-21 cells were trypsinized,
resuspended in GMEM and pelleted at 400 g for 5 min. The cells
were washed twice in PBS and resuspended in 800 ml PBS. The cell
suspension was added to the transcription mixture, which was then
transferred to an electroporation cuvette with a 4-mm gap. The cells
were pulsed twice at 850 V and 25 mF, resuspended in culture
medium, seeded into 10 cm2 wells and incubated at 37 uC. At 8 h
after electroporation, the cells were washed three times with culture
medium and subsequently incubated with fresh culture medium.
The culture medium was harvested 24 h after transfection, clarified
by centrifugation at 6500 g for 15 min and stored at 270 uC until
further use. To compare the transfection efficiencies of the con-
structs, immunostaining was performed and the numbers of posi-
tive cells were quantified with the Image-Pro Plus image analysis
software (Media Cybernetics). The transfection efficiencies were
observed to be equivalent within one experiment.
Table 1. Primers and probes used for site-directed mutagenesis, sequencing and RNA quantification
Primer Purpose Sequence (5§–3§)* Orientation PositionD
LV24 PCR AATCGGATCCTCAGGAAGCGTGCACACTGATGA 2 12419
LV96 PCR CCAACTGCAGACCGGATGTCC + 12015
LV293 PCR; StuI site CTAGTCTAGACTAGCTAGGCCTCCC 2 14091
LV294 PCR GP2-N173Q GCCGTTGGCcAgGTGAGCCTACAG + 12293
LV295 PCR GP2-N173Q CTGTAGGCTCACcTgGCCAACGGC 2 12293
LV296 PCR GP2-N179Q GCCTACAGTACcAgACCACGTTGG + 12310
LV297 PCR GP2-N179Q CCAACGTGGTcTgGTACTGTAGGC 2 12310
LV298 PCR GP5-N46Q CCAATACATATATcAgTTGACGATATGCGAGCTG + 13615
LV299 PCR GP5-N46Q CAGCTCGCATATCGTCAAcTgATATATGTATTGG 2 13615
LV300 PCR GP5-N53Q GACGATATGCGAGCTGcAgGGGACCGACTGG + 13634
LV301 PCR GP5-N53Q CCAGTCGGTCCCcTcCAGCTCGCATATCGTC 2 13634
LV371 PCR GCAGAACCATTCTCTTGGCATATGAGATGTTCTC + 13490
LV466II PCR; BstXI site CATTGCTTGTTTGTTCGCCATTCTCTTGGC + 13479
RT-OLE RT-PCR ORF7 TCGCCCTAAT 2 15041
L5 LightCycler ORF7 ATGKGGCTTCTCMGGSTTT 2 14744
iLC-PRRSV LightCycler ORF7 ATGGCCAGCCAGTCAAXTC + 14653
FL-PRRSV LightCycler ORF7 GCACCCAGCAACTGGCACAGTTGA 2 14669
*Restriction enzyme sites are indicated by underlining. Underlined nucleotides in lower case are mutated compared with the original genome
sequence of the PRRSV LV strain. K indicates G or T, M indicates A or C and S indicates C or G; X indicates the position of the label.
DRelative to the nucleotide sequence of PRRSV LV (GenBank accession no. M96262).
2 4 65'
1a 1b 3 5 7
AAA 3'
-wt-LV
-GP2-N173Q
-GP2-N179Q
-double mutant
-wt-NS
-GP5-N46Q
-GP5-N53Q
-double mutant
** **
Fig. 1. Schematic representation of the 39 part of the PRRSV
genome. The positions of the consensus sequences for
N-linked glycosylation in the translated ORF2 and ORF5 are
indicated (*). The designations of the constructs are shown
below the ORFs.
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Inoculation of PAMs. To investigate the infectivity of the mutant
viruses, 200 ml aliquots of the culture supernatants of transfected
BHK-21 cells were used to inoculate PAMs. After 1 h, fresh culture
medium was added. At 24 h after incubation at 37 uC, the cells were
washed with PBS, dried and stored at 220 uC until immunostaining
was performed.
Virus titres (expressed as TCID50 ml
21) were determined on PAMs
by end-point dilution (Wensvoort et al., 1986). Twenty-four hours
post-infection (p.i.), infected cells were assessed in an immuno-
staining assay (IPMA) based on the nucleocapsid protein.
Immunoperoxidase monolayer assay (IPMA). Immunostaining
of BHK-21 cells and PAMs was performed by the method described
by Wensvoort et al. (1986). mAb 122.17 was used to detect expres-
sion of the PRRSV N protein.
Preparation of radiolabelled virions. At 15 h post-transfection
(p.t.), BHK-21 cells were washed three times with starvation medium
(MEM-E without L-methionine, L-cysteine and L-glutamine; ICN)
and subsequently incubated with starvation medium supplemented
with 1?5 mg methionine ml21, 24 mg cysteine ml21, 1 % L-glutamine,
100 U penicillin ml21, 100 U streptomycin ml21 and 5 % dialysed
FCS. After 1 h, 157?5 mCi Tran[35S]-label (ICN) was added and the
cells were further incubated for 8 h at 37 uC. After clarification of
the culture supernatants at 6500 g for 10 min at 4 uC, labelled virus
particles were pelleted through a 0?5 M sucrose cushion (in TNE;
20 mM Tris/HCl, pH 7?6, 100 mM NaCl, 1 mM EDTA) by ultra-
centrifugation (Beckman R65 rotor; 200 000 g for 3 h at 4 uC). The
virus pellets were then dissolved in 450 ml PBS-TDS (1 % Triton
X-100, 0?5 % sodium deoxycholate and 0?1 % SDS) supplemented
with protease inhibitors (25 mg Pefabloc-Sc, 0?7 mg pepstatin, 1 mg
aprotinin and 0?5 mg leupeptin ml21).
Radioimmunoprecipitation and gel electrophoresis. Solubilized
virions were incubated overnight at 4 uC in the presence of the appro-
priate antibody. The next day, 3 mg protein A–Sepharose was added
to each sample and the samples were incubated at 4 uC for another
2 h. Immune complexes were washed three times with PBS-TDS,
resuspended in 30 ml 26 NuPAGE LDS sample buffer supplemented
with 50 mM DTT and heated for 5 min at 100 uC. Samples were
analysed by SDS-PAGE using a 12 % polyacrylamide gel. Gels were
fixed for at least 10 min in 40 % (v/v) methanol and 10 % (v/v) acetic
acid and dried on Whatman 3MM paper and radioactivity was
visualized by phosphorimaging (STORM-840).
RNA isolation and quantification. To investigate the relative
amounts of viral genomic RNA (as a measure of total virus
particles), a real-time RT-PCR was performed with primers posi-
tioned at the junction of ORF6 and ORF7 using the LightCycler
(Roche) as described before (Jacobs et al., 2000). At 24 h p.t., BHK-
21 culture supernatant was harvested and cleared by centrifugation
for 15 min at 6500 g. Viral RNA was isolated from 200 ml of each
supernatant with the High Pure RNA isolation kit (Roche). The
PCR was performed using the LightCycler RNA amplification kit
hybridization probes (Roche). PCR mixtures consisted of 6?5 mM
MgCl2, 0?2 mM reverse primer L5, 0?2 mM of an internal LC640-
labelled forward primer (iLC-PRRSV), 0?15 mM of a 39-fluorescein-
labelled Hybprobe (FL-PRRSV; see Table 1) and 10 ml RNA eluate.
PCR conditions were as followed: RT step of 30 min at 50 uC, a hot
start for 30 s at 95 uC, followed by 45 PCR cycles of 1 s at 95 uC, 5 s
at 53 uC and 10 s at 72 uC. The relative amounts of viral genomic
RNA were determined by extrapolation from a linear standard
curve. For this purpose, pABV437 was transcribed in vitro, the RNA
was purified using the RNA isolation kit and the amount of RNA
was estimated on an agarose gel.
Sequence analysis of genomic RNA of recombinant viruses.
Viral RNA in the culture supernatant of BHK-21 cells was isolated
using the High Pure RNA isolation kit (Roche). The RNA was
reverse-transcribed with antisense ORF7 RT primer (Oleksiewicz
et al., 1998). PCRs were performed with sense primer LV466II and
antisense primer LV293 flanking ORF5 (Table 1). The amplified
fragments were sequenced using both PCR primers. Sequences were
determined with the PRISM Ready Dye Deoxy Terminator cycle
sequencing kit and an ABI PRISM 310 Genetic Analyzer (Perkin
Elmer).
Statistical analysis. Overall equality of the wild-type and mutant
viruses with respect to virus production, as determined by RT-PCR,
and virus infectivity was tested using the Kruskal–Wallis test.
Pairwise comparisons were made using the permutation test.
Significance levels were set at 5 %. Statistical analyses were per-
formed with StatXact-5 for Windows (Cytel Software Corporation).
RESULTS
Mutagenesis and expression of GP2 and GP5
proteins
To study the significance of the N-linked oligosaccharides
on the GP2a and GP5 proteins in the PRRSV life cycle,
mutant full-length cDNA clones were generated in which
the codons for each of the relevant asparagine residues were
replaced by a codon for glutamine. Six recombinant full-
length cDNA clones were thus obtained: GP2a-N173Q,
GP2a-N179Q, GP2a-double mutant, GP5-N46Q, GP5-N53Q
and GP5-double mutant (Fig. 1).
To confirm the use of the predicted N-glycosylation sites
and to investigate whether the mutations affect the
expression and processing of the respective proteins, the
mutant and wild-type glycoproteins were assessed using
SDS-PAGE (Fig. 2a). The proteins were expressed by
transfection of BHK-21 cells, which are non-permissive
for PRRSV, with full-length transcripts of the mutant and
parental clones (wt-LV and wt-NS) and immunoprecipi-
tated from extracellular virions that were produced by the
transfected cells. Assessment of the glycoproteins in the
context of extracellular virions was necessary as the proteins
were hard to detect in transfected cell lysates due to the
limited transfection levels. The extracellular virions were
concentrated through a sucrose cushion, which resulted
in less background and increased quantities of the glyco-
proteins. In addition, by this approach, the incorporation
of the mutant proteins into virions could be verified
simultaneously.
The electrophoretic mobilities of the mutant proteins were
as predicted (Fig. 2a). The mobility shift corresponding to
the apparent removal of about 2?5 kDa seen with every
mutation demonstrated that each of the theoretical
glycosylation sites is actually used and that the mutations
had been effectively introduced. As is known for the GP2
and GP5 glycoproteins of PRRSV (Meulenberg et al., 1995;
Meulenberg & Petersen-den Besten, 1996), both wild-type
proteins appeared in the gel as somewhat diffuse bands,
indicative of heterogeneous maturation of the oligosacchar-
ides. This was also the case, though less pronounced, for the
mutant proteins lacking one of the oligosaccharide side
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chains, but not for the proteins lacking both sugars. The
mutant GP2a and GP5 proteins seemed to be correctly
expressed, although the intensity of the GP5 protein bands
of the N46Q mutants was greatly reduced. This reduction
might be due either to reduced incorporation of these pro-
teins in PRRSV virions or to reduced particle production.
Analysis of the effect of the mutations on the
production of virus particles
To investigate whether this reduced intensity resulted from
decreased production of virus particles, radioimmuno-
precipitation assays were performed using an anti-N anti-
body (Fig. 2b). No substantial differences were observed in
the intensity of the nucleocapsid protein bands immuno-
precipitated from the two wild-type viruses, the GP2a
mutants and the GP5-N53Q mutant. In contrast, the GP5-
N46Q mutation appeared to reduce the formation or release
of particles dramatically, as judged by the small amounts of
N protein precipitated from both mutants carrying this
mutation. We conclude that the N-linked glycans normally
present on the GP2a protein are not essential for particle
formation, as is the oligosaccharide attached to N53 of the
GP5 protein, but that the oligosaccharide linked to N46 of
the GP5 protein is strongly required.
Analysis of the effect of the mutations on the
production of infectious virus
To investigate how the introduced mutations affect the
production of infectious virus, equal volumes of the culture
supernatants of transfected BHK-21 cells were used to
inoculate PAMs, which are susceptible to PRRSV. At 24 h
p.i., the cells were immunostained with an anti-N anti-
body (Fig. 3). Particles produced by the three GP2a mutants
appeared to be able to infect PAMs to the same extent as
wild-type virus particles. Of the GP5 glycosylation mutants,
the GP5-N53Q mutant showed a slight reduction in the
number of positive macrophages (approx. 70 % of wt-
NS). The GP5-N46Q mutant and the GP5 double mutant,
however, showed a dramatically different phenotype. These
two mutants were strongly affected in their ability to pro-
duce infectious progeny virus, as could be concluded from
the marginal number of positive macrophages (approx.
1–2 % of wt-NS).
Characterization of the GP5-N46Q mutants
Since the elimination of the glycosylation site at position
46 was highly detrimental for infectious virus production,
we were interested in determining whether the introduced
mutations were maintained in the GP5-N46Q and GP5-
double mutants. Genomic RNA was isolated from progeny
virus present in the culture supernatant of the transfected
BHK-21 cells. The 39 end of the genome encompassing
the ORF5 gene was reverse-transcribed and the ORF5
genes were amplified and sequenced. It appeared that the
introduced mutations were still present in both cases and
that no additional mutations had been introduced in ORF5.
Analysis of the effect of the mutations on
specific infectivity
To investigate the impact of the mutations on the specific
infectivities of the mutant virus particles, i.e. their
infectivity-to-particle ratio, we determined both the
amount of genomic viral RNA (as a measure of viral
particles) and the virus titre in the culture supernatant of
transfected cells for each virus. For this purpose, BHK-21
cells were transfected in triplicate with full-length wild-
type and mutant RNA transcripts. After 24 h, cell culture
supernatants were harvested and cleared. Equal volumes
from each cleared supernatant were taken to quantify
comparatively the amount of viral RNA released into the
medium. This was done by performing a real-time RT-PCR
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Fig. 2. Effect of the introduced mutations on expression and
processing of PRRSV GP2 and GP5 proteins (a) and on virus
particle production (b). (a) BHK-21 cells were transfected with
in vitro transcripts of the full-length cDNA clones and labelled
with Tran[35S]label from 16 to 24 h p.t. After clarification of the
supernatant, extracellular virions were pelleted through a 0?5 M
sucrose cushion. Pellets were dissolved in PBS-TDS and sub-
jected to immunoprecipitation with anti-GP2 or anti-GP5 anti-
bodies. The supernatant of BHK-21 cells transfected with an
in vitro transcript of pABV952, a replication-negative mutant
(unpublished results), was used as a negative control. Immuno-
precipitated proteins were analysed by 12% SDS-PAGE.
Arrows indicate the positions of the proteins; N indicates the
nucleocapsid protein that is immunoprecipitated non-specifically
(Meulenberg & Petersen-den Besten, 1996). Molecular mass
marker proteins are shown (kDa) in the left lane of each panel.
(b) Immunoprecipitation analysis of recombinant viruses. Radio-
labelled particles were generated and processed as described
in (a). mAb 122.17 was used to precipitate the N protein.
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on the RNA isolated from each sample with reference to
an RNA standard. The results did not reveal statistically
significant differences in RNA yields for the GP2a mutant
viruses compared with the parental virus (wt-LV) (Fig. 4a).
The same held true for the GP5-N53Q mutant when
compared with its corresponding parental virus (wt-NS).
However, for the two GP5 mutants carrying the N46Q
mutation, viral RNA levels were significantly reduced to a
level that was 10 to 20 times lower than that of wt-NS and
the GP5-N53Q mutant. It is worth noting that the reduc-
tion in RNA yields is consistent with the observed reduction
in the amounts of N protein immunoprecipitated from the
GP5-N46Q mutant viruses (see Fig. 2b).
Assuming that the amount of viral RNA in the culture
medium, as measured by RT-PCR, reflects the number of
viral particles, we normalized the culture supernatants to an
equal number of viral particles. We then determined the
infectivity titres of these supernatants by performing end-
point dilution titrations on PAMs in triplicate (Fig. 4b).
Obviously, the intrinsic infectivities of the GP2a mutant
particles are not much affected by the absence of the
oligosaccharides. On the other hand, the absence of the
N-glycan at position 53 of GP5 reduced the infectivity of
the mutant virus, though not to a statistically significant
extent. Remarkably, the absence of the oligosaccharide
linked to N46 of GP5 significantly reduced the infectivity
of the mutant viruses 10- to 20-fold in addition to the
adverse effect on virus production.
DISCUSSION
In this study, we investigated the significance of theN-linked
glycans on PRRSV GP2a and GP5 for virus production and
viral infectivity. The results indicate that the importance
of the N-linked glycans present on the envelope proteins of
PRRSV can vary significantly. On the one hand, we observed
that the N-glycans normally present on the GP2a protein
and the N-glycan attached to N53 of the GP5 protein are
essential for neither virus particle formation nor viral
infectivity. On the other hand, the glycan linked to N46 of
the GP5 protein was found to be important both for the
production of extracellular virions and for PRRSV infec-
tivity. The observed reduction in specific infectivity of the
GP5-N46Q mutants was statistically significant and about
10- to 20-fold. Together with the similar reduction in the
production of virus particles, the combined effects account
for the observed overall reduction in infectious virus yields
(approx. 100-fold) of the GP5-N46Q mutants (see Fig. 3).
The GP2a protein of PRRSV LV has two putative glyco-
sylation sites at asparagine residues 173 and 179. Both sites
are extremely well conserved. In fact, the only strain known
to contain one site, the one corresponding to N173 in LV,
is the live attenuated vaccine strain Primepac (GenBank
accession no. AF066384). As both sites appeared to be
actually used, the oligosaccharides are likely to serve
important biological functions. It may therefore seem
surprising that mutations preventing the attachment of an
oligosaccharide at either one or both sites had no obvious
wt-LV GP2-N173Q GP2-N179Q GP2-double
wt-NS GP5-N46Q GP5-N53Q GP5-double
Fig. 3. Analysis of the production of infectious virus by BHK-21 cells transfected with mutant full-length RNA transcripts.
Culture supernatants of transfected BHK-21 cells were used to inoculate PAMs. At 24 h p.i., the macrophages were
immunostained with mAb 122.17 directed against the N protein.
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consequences, neither on the formation nor on the infec-
tivity of virions. The observations are, however, consistent
with results showing that the GP2 protein is dispensable
for particle assembly. By disrupting expression of the GP2
gene using an infectious PRRSV cDNA clone, we found
that particles are still produced but that these particles are
non-infectious (E. H. J. Wissink, M. V. Kroese, H. A. R.
van Wijk, F. A. M. Rijsewijk, J. J. M. Meulenberg and
P. J. M. Rottier, unpublished results). These studies also
showed that the GP2a protein is assembled into virions as
a heteromultimeric complex together with the GP3, GP4
and E proteins and that this complex is required to render
particles infectious. The lack of N-linked sugars on GP2a
apparently does not affect the formation of the complex or
its functioning in the cell culture infection system.
These observations certainly do not imply that the oligo-
saccharides attached to GP2a are irrelevant. Rather, their
conservation suggests them to endow the virus with a
distinct advantage in the natural host. How the virus may
benefit from having the GP2a glycans is unclear, as the
oligosaccharides can act at many different levels. One is
the level of the receptor. As we (E. H. J. Wissink, M. V.
Kroese, H. A. R. van Wijk, F. A. M. Rijsewijk, J. J. M.
Meulenberg and P. J. M. Rottier, unpublished results) and
others (Wieringa, 2003) have hypothesized, the multimeric
complex composed of the minor proteins functions in
targeting and cell entry. As has been shown by Ohuchi
et al. (1997) for the influenza virus HA protein, the
N-glycans adjacent to the receptor binding site can control
the receptor affinity of the virus. Another level at which the
GP2a-linked sugars might act is the immune system. Several
studies have shown that the oligosaccharides can shield
critical epitopes from immune recognition (see for example
Back et al., 1994; Huso et al., 1988; Johnson et al., 2003).
Such an effect might explain why no monoclonal antibodies
have been obtained against the PRRSV GP2a protein.
Furthermore, in a recent study on the efficacy of DNA
vaccination against PRRSV infection using a set of con-
structs expressing the structural protein genes, no anti-
bodies were detected against the GP2a protein (I. F. A.
van der Linden, H. A. R. van Wijk, E. H. J. Wissink, P. A.
van Rijn, J. J. M. Meulenberg and P. J. G. M. Steverink,
unpublished results). It would therefore be interesting to
evaluate whether the antigenicity of single- or non-
glycosylated GP2a in the natural host is qualitatively and
quantitatively different from that of the wild-type form.
Results of such studies might also be relevant for an
understanding of the protective features of the Primepac
vaccine strain.
The GP5 protein of LV has two N-glycosylation sites, at
positions 46 and 53, both of which we showed to be actually
occupied in the wild-type protein. As for GP2, these two sites
are highly conserved in North American- and European-
type PRRSV strains. They are also conserved in non-
neuropathogenic strains of LDV (Chen et al., 2000), while
in neuropathogenic strains the site corresponding to posi-
tion 46 is always lacking. Despite this high conservation of
the sugar attached to N53, preventing glycosylation at this
site had no severe effects on mutant particle formation or
on the infectivity of such particles. As argued above for
GP2a, this glycan probably has its significance in the natural
host.
Preventing glycosylation of the GP5 protein at position
N46 had dramatic effects at two different levels. Both for the
single mutant and for the mutant lacking both glycans,
virion production and virion infectivity were strongly
reduced. The former effect may have a number of reasons.
First of all, the absence of the oligosaccharide can lead to
improper folding of the GP5 protein. N-Glycans located
near the N terminus of a protein, more specifically those
within the 50 most N-terminal amino acids, often play a
Fig. 4. (a) Quantification of relative amounts of viral RNA in
transfection supernatants. For each series of viruses, BHK-21
cells were transfected in triplicate with full-length RNA tran-
scripts. At 24 h p.t., culture supernatants were harvested and
cleared by low-speed centrifugation. Subsequently, viral RNA
was isolated from equal volumes of the supernatants and a
real-time RT-PCR was performed. * vs ** indicates a statistically
significant difference (P¡0?05) between wt-NS and the GP5-
N53Q mutant on the one hand and the GP5-N46Q and GP5-
double mutants on the other hand. (b) Specific infectivities of
the mutant viruses. For each series of viruses, culture super-
natants were normalized to an equal number of viral particles
(i.e. the amount of RNA). Subsequently, the infectivity titres of
these supernatants were determined by performing end-point
dilution titrations on PAMs. * vs ** indicates a statistically signi-
ficant difference (P¡0?05) between wt-NS on the one hand
and GP5-N46Q and GP5-double jointly on the other hand.
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pivotal role in the folding process by interacting with
folding chaperones in the endoplasmic reticulum (ER)
(reviewed by Helenius & Aebi, 2001). Furthermore, N-
glycans located in the vicinity of a cysteine residue have
been suggested to protect these cysteines from improper
and premature formation of disulphide bonds (Daniels
et al., 2003; Hebert et al., 1997). Actually, the N-glycan at
position 46 is very close to Cys50, the residue presumed to
be involved in GP5–M protein linkage (Verheije, 2002). In
this respect it is remarkable that the sole PRRSV strains
known to lack the N-glycan at position 46 instead have a
nearby glycosylation site at position 37 (Mateu et al., 2003;
Stadejek et al., 2002), suggesting that these glycans can
adopt each other’s function. As GP5–M disulphide-bond
formation is essential for arterivirus assembly (Snijder
et al., 2003; Verheije, 2002), an effect of the GP5-N46Q
mutation on this process might explain the reduced mutant
virion production levels.
Improper folding of the GP5 protein caused by the muta-
tion may also affect the intracellular transport of the pro-
tein. Only properly folded proteins pass the quality control
system of the ER and are allowed to exit the compartment.
The GP5 protein has to move to and accumulate at the site
of virion budding, which is located in the ER, the inter-
mediate compartment or the Golgi complex (Dea et al.,
2000; Magnusson et al., 1970; Pol & Wagenaar, 1992).
Assuming that GP5–M heterodimerization occurs in the
ER, impaired transport of the dimeric complexes will affect
the efficiency of budding. The transport of budded virions
through the Golgi apparatus to the plasma membrane
might also suffer from improper folding of the GP5 protein.
Any of these transport defects will result in reduced release
of virions from the infected cell.
The GP5-N46Q mutation also significantly lowered the
specific infectivity of the mutant viruses. This would have
been a logical observation if the GP5 protein, or the GP5–M
complex, was involved in targeting of the virus to its
receptor on the host cell. However, studies in which the
ectodomain of the GP5 protein of EAV (Dobbe et al., 2001)
or of the M protein of PRRSV (Verheije et al., 2002) was
replaced by corresponding domains from other arteriviruses
showed that these changes do not lead to altered viral
tropism. A role of GP5 in interaction with the primary
receptor is therefore unlikely. Still, there are several steps
in the post-binding process of virus entry that might be
hampered by the N46Q mutation and thus cause the
reduced viral infectivity. One early step might involve the
interaction with heparin-like molecules at the target cell
surface described by Delputte et al. (2002). Other steps
might, for instance, involve the process of endocytosis of
bound virions and, once within the endosome, the merging
of the virion and endosomal membranes that leads to the
delivery of the nucleocapsid into the cell cytoplasm. Clearly,
we will need to learn more about the molecular details of
these processes in order to understand the mechanisms
behind our observations.
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